APA (7th ed.) Citation

S, X., SY, Y., ZX, B., YM, L., J, Q., YD, M., . . . XG, L. (2025). Personalized drug screening of patient-derived tumor-like cell clusters based on specimens obtained from percutaneous transthoracic needle biopsy in patients with lung malignancy: A real-world study. BMC cancer, 25(1), 649. https://doi.org/10.1186/s12885-025-14069-0

Chicago Style (17th ed.) Citation

S, Xu, Yin SY, Bie ZX, Li YM, Qi J, Ma YD, Wang Z, Xi JJ, and Li XG. "Personalized Drug Screening of Patient-derived Tumor-like Cell Clusters Based on Specimens Obtained from Percutaneous Transthoracic Needle Biopsy in Patients with Lung Malignancy: A Real-world Study." BMC Cancer 25, no. 1 (2025): 649. https://doi.org/10.1186/s12885-025-14069-0.

MLA (9th ed.) Citation

S, Xu, et al. "Personalized Drug Screening of Patient-derived Tumor-like Cell Clusters Based on Specimens Obtained from Percutaneous Transthoracic Needle Biopsy in Patients with Lung Malignancy: A Real-world Study." BMC Cancer, vol. 25, no. 1, 2025, p. 649, https://doi.org/10.1186/s12885-025-14069-0.